ProfileGDS4718 / 208791_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 78% 85% 97% 71% 82% 61% 45% 78% 91% 83% 75% 97% 45% 53% 44% 91% 88% 48% 52% 39% 86% 83% 75% 85% 81% 63% 87% 62% 74% 34% 57% 92% 84% 65% 73% 75% 45% 91% 90% 98% 85% 56% 85% 53% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.6344878
GSM549102patient 115, normal, homogenized [OPG study]8.3462985
GSM549104patient 119, normal, homogenized [OPG study]11.155797
GSM549108patient 138, normal, homogenized [OPG study]6.8795171
GSM549119patient 077, normal, homogenized [OPG study]8.0312982
GSM549133patient 032, cancer, homogenized [OPG study]6.1901961
GSM549139patient 042, cancer, homogenized [OPG study]5.199145
GSM549099patient 107, normal, homogenized [OPG study]7.523778
GSM549109patient 139, normal, homogenized [OPG study]9.3066291
GSM549110patient 046, normal, homogenized [OPG study]8.2459383
GSM549114patient 063, normal, homogenized [OPG study]7.3415775
GSM549122patient 082, normal, homogenized [OPG study]10.905197
GSM549134patient 033, cancer, homogenized [OPG study]5.238445
GSM549136patient 036, cancer, homogenized [OPG study]5.6191153
GSM549140patient 044, cancer, homogenized [OPG study]5.1356144
GSM549111patient 047, normal, homogenized [OPG study]9.4244291
GSM549113patient 057, normal, homogenized [OPG study]9.0791888
GSM549132patient 031, cancer, homogenized [OPG study]5.3721148
GSM549137patient 038, cancer, homogenized [OPG study]5.6050852
GSM549142patient 047, cancer, homogenized [OPG study]5.0630339
GSM549100patient 110, normal, homogenized [OPG study]8.5096986
GSM549107patient 135, normal, homogenized [OPG study]8.3061883
GSM549115patient 068, normal, homogenized [OPG study]7.4384375
GSM549116patient 072, normal, homogenized [OPG study]8.5835485
GSM549120patient 078, normal, homogenized [OPG study]7.9300581
GSM549131patient 030, cancer, homogenized [OPG study]6.3537763
GSM549118patient 074, normal, homogenized [OPG study]8.7670987
GSM549129patient 027, cancer, homogenized [OPG study]6.2703362
GSM549123patient 088, normal, homogenized [OPG study]7.2685874
GSM549124patient 006, cancer, homogenized [OPG study]4.7666734
GSM549126patient 015, cancer, homogenized [OPG study]5.9296957
GSM549128patient 025, cancer, homogenized [OPG study]9.4718392
GSM549103patient 117, normal, homogenized [OPG study]8.138284
GSM549117patient 073, normal, homogenized [OPG study]6.4287965
GSM549138patient 041, cancer, homogenized [OPG study]7.204573
GSM549141patient 045, cancer, homogenized [OPG study]7.4068375
GSM549130patient 028, cancer, homogenized [OPG study]5.2653945
GSM549101patient 111, normal, homogenized [OPG study]9.2864491
GSM549105patient 128, normal, homogenized [OPG study]9.1860290
GSM549106patient 134, normal, homogenized [OPG study]11.679398
GSM549112patient 048, normal, homogenized [OPG study]8.5224285
GSM549125patient 011, cancer, homogenized [OPG study]5.8780556
GSM549127patient 024, cancer, homogenized [OPG study]8.4346285
GSM549135patient 035, cancer, homogenized [OPG study]5.6612453